NEW YORK (GenomeWeb News) – Thermo Electron and Fisher Scientific International today said that their shareholders have approved their merger.
The companies said that the deal, the largest ever in the biotech industry, remains subject to regulatory approval.
As GenomeWeb News reported this week, Fisher said it would divest an undisclosed product line to satisfy the Federal Trade Commission. The line is worth $17 million, Fisher said.
As originally expected, the $10.6 billion deal is scheduled to close by the end of the fourth quarter. The firms announced the deal in May.